Viewing Study NCT07400094

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-05-04 @ 10:59 AM
Study NCT ID: NCT07400094
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-10
First Post: 2026-01-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC
Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Squamous Cell Carcinoma of Head and Neck View
None Laryngeal Neoplasms View
None Oral Cavity Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Head and Neck Squamous Cell Carcinoma View
None Neoadjuvant Therapy View
None Camrelizumab View
None Paclitaxel View
None Carboplatin View
None Pathological Complete Response View
None PD-1 Inhibitor View